Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types
-
Published:2024-01-05
Issue:
Volume:
Page:ard-2023-225179
-
ISSN:0003-4967
-
Container-title:Annals of the Rheumatic Diseases
-
language:en
-
Short-container-title:Ann Rheum Dis
Author:
Tchitchek NicolasORCID,
Binvignat MarieORCID,
Roux Alexandra,
Pitoiset Fabien,
Dubois Johanna,
Marguerit Gwendolyn,
Saadoun David,
Cacoub Patrice,
Sellam Jérémie,
Berenbaum FrancisORCID,
Hartemann Agnès,
Amouyal Chloé,
Lorenzon RobertaORCID,
Mariotti-Ferrandiz EncarnitaORCID,
Rosenzwajg MichelleORCID,
Klatzmann DavidORCID
Abstract
ObjectivesBased on genetic associations, McGonagle and McDermott suggested a classification of autoimmune and autoinflammatory diseases as a continuum ranging from purely autoimmune to purely autoinflammatory diseases and comprising diseases with both components. We used deep immunophenotyping to identify immune cell populations and molecular targets characterising this continuum.MethodsWe collected blood from 443 patients with one of 15 autoimmune or autoinflammatory diseases and 71 healthy volunteers. Deep phenotyping was performed using 13 flow cytometry panels characterising over 600 innate and adaptive cell populations. Unsupervised and supervised analyses were conducted to identify disease clusters with their common and specific cell parameters.ResultsUnsupervised clustering categorised these diseases into five clusters. Principal component analysis deconvoluted this clustering into two immunological axes. The first axis was driven by the ratio of LAG3+ to ICOS+ in regulatory T lymphocytes (Tregs), and segregated diseases based on their inflammation levels. The second axis was driven by activated Tregs and type 3 innate lymphoid cells (ILC3s), and segregated diseases based on their types of affected tissues. We identified a signature of 23 cell populations that accurately characterised the five disease clusters.ConclusionsWe have refined the monodimensional continuum of autoimmune and autoinflammatory diseases as a continuum characterised by both disease inflammation levels and targeted tissues. Such classification should be helpful for defining therapies. Our results call for further investigations into the role of the LAG3+/ICOS+ balance in Tregs and the contribution of ILC3s in autoimmune and autoinflammatory diseases.Trial registration numberNCT02466217.
Funder
Assistance publique-Hôpitaux de Paris
Investissements d’Avenir programme
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology